Fungal infections and treatment in cystic fibrosis

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 6, 2013, Pages 670-675

  Middleton, Peter G ^a   Chen, Sharon C A ^a,b   Meyer, Wieland ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

cystic fibrosis; epidemiology; fungal; treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; GLIOTOXIN; ITRACONAZOLE; PLACEBO; VITAMIN D RECEPTOR; VORICONAZOLE;

ACREMONIUM; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ALTERNARIA; ANTIBIOTIC THERAPY; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS VERSICOLOR; ASTHMA; AUREOBASIDIUM PULLULANS; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CLADOSPORIUM; CULTURE MEDIUM; CURVULARIA; CYSTIC FIBROSIS; EXERCISE TOLERANCE; EXOPHIALA; FORCED EXPIRATORY VOLUME; FUNGAL COLONIZATION; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; FUSARIUM CULMORUM; HEAT TREATMENT; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; LUNG FIBROSIS; LUNG FUNCTION; LUNG LAVAGE; MALASSEZIA; MULTICENTER STUDY (TOPIC); MYCOSIS; NEBULIZATION; NONHUMAN; PAECILOMYCES; PENICILLIUM; PENICILLIUM CITREONIGRUM; PHOTOSENSITIVITY DISORDER; PHYSIOTHERAPY; POLYMERASE CHAIN REACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHIZOPUS; RHODOTORULA; SACCHAROMYCES CEREVISIAE; SCEDOSPORIUM; SCEDOSPORIUM APIOSPERMUM; SPUTUM CULTURE; STOMACH PH; THANATEPHORUS CUCUMERIS; THRUSH; TRICHOSPORON;

ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; CANDIDA; CANDIDIASIS; CYSTIC FIBROSIS; DNA, FUNGAL; FEMALE; HUMANS; ITRACONAZOLE; MALE; PYRIMIDINES; SCEDOSPORIUM; SPUTUM; TRIAZOLES; VITAL CAPACITY;

EID: 84885186517     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328365ab74     Document Type: Review

References (17)

1. Pihet M, Carrere J, Cimon B, et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis -a review. Med Mycol 2009; 47:387-397.
2. Blyth CC, Harun A, Middleton PG, et al. Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. J Clin Microbiol 2010; 48:314-316.
3. Nagano Y, Elborn JS, Millar BC, et al. Comparison of techniques to examin. The diversity of fungi in adult patients with cystic fibrosis. Med Mycol 2010; 48:166-176.
4. Harun A, Blyth CC, Gilgado F, et al. Development and validation of a multiplex PCR for detection of Scedosporium spp. in respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol 2011; 49:1508-1512.
5. Delhaes L, Monchy S, Frealle E, et al. The airway microbiota in cystic fibrosis\: A complex fungal and bacterial community-implications for therapeutic management. PLoS One 2012; 7:e36313.
6. Kraemer R, Delosea N, Ballinari P, et al. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2006; 174:1211-1220.
7. Denning DW, Van Wye JE, Lewiston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991; 100:813-819.
8. Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 2010; 137:171-176.
9. Blyth CC, Middleton PG, Harun A, et al. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors? Med Mycol 2010; 48 (Suppl 1):S37-S44.
10. Chotirmall SH, O'Donoghue E, Bennett K, et al. Sputum Candida albicans presages FEV1 decline and hospital-treated exacerbations in cystic fibrosis. Chest 2010; 138:1186-1195.
11. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342:756-762.
12. Burgel PR, Baixench MT, Amsellem M, et al. High prevalence of azoleresistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob Agents Chemother 2012; 56:869-874.
13. Rondeau S, Couderc L, Dominique S, et al. High frequency of voriconazolerelated phototoxicity in cystic fibrosis patients. Eur Respir J 2012; 39:782-784.
14. Aaron SD, Vandemheen KL, Freitag A, et al. Treatment of Aspergillus fumigatus in patients with cystic fibrosis\: A randomized, placebo-controlled pilot study. PLoS One 2012; 7:e36077.
15. Coughlan CA, Chotirmall SH, Renwick J, et al. The effect of Aspergillus fumigatus infection on vitamin D receptor expression in Cystic Fibrosis. Am J Respir Crit Care Med 2012; 186:999-1007.
16. Kreindler JL, Steele C, Nguyen N, et al. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4þ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest 2010; 120:3242-3254.
17. Baxter CG, Rautemaa R, Jones AM, et al. Intravenous antibiotics reduc. The presence of Aspergillus in adult cystic fibrosis sputum. Thorax 2013; 68:652-657.